Pre-commercial procurement of affordable solutions for healthcare systems in the areas of cancer technologies, cancer medical devices, or cancer medicines

Grantavia

P

Funding Match^Beta

We use essential, analytics, and advertising cookies to improve the experience, measure usage, and optimize campaigns.

Essential

Required for the site to function and cannot be disabled.

Analytics

Help us understand usage to improve the service.

Advertising

Allow us to measure campaigns and optimize advertising related to our services.

Learn more at Privacy Policy · Terms of Service · Cookie Policy

Description

Europe

Health & Life Sciences•100% • 26M€

Open — Sep 16 (343d)

Dates & Deadlines

Publication Date

October 5, 2026

Opening Date

February 10, 2026

Application Phases

Fase única

September 16, 2027 at 05:00 PM

343 days left

Financial Details

Non-Refundable

Maximum Funding Rate

100%

Budget

26M€

Eligible Project Value

8M€ - 10M€

Maximum Duration

60 months

Criteria & Documents

Eligible Expenses

●Personnel Costs
●Travel costs
●Equipment costs
●Other goods, works and services costs
●Subcontracting
●Indirect Costs

Access Conditions

●Legal entities from EU Member States and Associated Countries
●Consortium must include partners from at least three different EU Member States or Associated Countries
●Compliance with general and specific admissibility and eligibility criteria

Selection Criteria

●Excellence (scientific and technical merit)
●Impact (contribution to policy and partnership KPIs)
●Quality and efficiency of implementation

Mandatory Information

●Application form (Part A and Part B)
●Budget

Result Indicators

●Research publications
●Patent filings
●Clinical guidelines
●Implementation in health systems

EU Programme Details

Call ID: HORIZON-MISS-2027-02-CANCER-05
Cluster: Mission
Destination: Cancer
Submission Mode: Single-stage
EU Contribution: Around €8,000,000.00 to €10,000,000.00 per project
Expected Projects: 3 projects
Funding Rate Rule: The action is funded under Horizon Europe PCP rules, which allow reimbursement of up to 100% of eligible project costs for the beneficiaries involved in the procurement action

Funding Rate

100%

Budget

26M€

Days Left

343

Sep 16

Curated by

Marlene Faria

Eligibility

Eligible Sectors

Health & Life Sciences

Company Typologies

MicroSMESmall Mid-CapMid-CapLargePrivate non-profit entitiesPublic entities

Application Mode

Consortium / Copromotion

Action Types

Pre-Commercial ProcurementClinical studiesTranslational researchPrevention and early detection initiativesTherapy developmentPatient support

Official Links

Official Regulation

Cookies